Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SPRB US Equity

Spruce Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1683553 · FY ends Dec 31
$52.96
+0.12 (+0.22%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 7 13G
DateEventWhat happened / filerSource
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by ORBIMED ADVISORS LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by ADAR1 Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by CITADEL ADVISORS LLCsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by AWM Investment Company, Inc.sec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by INTEGRATED CORE STRATEGIES (US) LLCsec.gov ↗
2026-07-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by HIRSCHMAN ORINsec.gov ↗
2026-07-278-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-27

Every row is a filed document, checked against its EDGAR index.